✦ LIBER ✦

A multi-institutional Phase III study of nabilone vs. placebo in chemotherapy-induced nausea and vomiting

✍ Scribed by Jones, Stephen E.; Durant, John R.; Anthony Greco, F.; Robertone, Aurelia

Book ID: 123460978
Publisher: Elsevier Science
Year: 1982
Tongue: English
Weight: 329 KB
Volume: 9
Category: Article
ISSN: 0305-7372
DOI: 10.1016/S0305-7372(82)80035-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Nabilone vs. placebo in the treatment of

Nabilone vs. placebo in the treatment of chemotherapy-induced nausea and vomiting in cancer patients

✍ Levitt, Martin 📂 Article 📅 1982 🏛 Elsevier Science 🌐 English ⚖ 257 KB

Olanzapine Versus Aprepitant for the Pre

Olanzapine Versus Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Randomized Phase III Trial

✍ Rudolph M. Navari; Sarah E. Gray; Andrew C. Kerr 📂 Article 📅 2011 🏛 Frontline Medical Communications, Inc. 🌐 English ⚖ 773 KB

Phase I-trial of clebopride, a new antie

Phase I-trial of clebopride, a new antiemetic, in chemotherapy — induced nausea and vomiting

✍ H. J. Lenz; U. Schuler; W. Hicking; G. Ehninger 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 109 KB

Efficacy and tolerability of transdermal

Efficacy and tolerability of transdermal granisetron for the control of chemotherapy-induced nausea and vomiting associated with moderately and highly emetogenic multi-day chemotherapy: a randomized, double-blind, phase III study

✍ Ralph V. Boccia; Lucio N. Gordan; Gemma Clark; Julian D. Howell; Steven M. Grunb 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 185 KB

## Purpose A novel transdermal formulation of granisetron (the granisetron transdermal delivery system (GTDS)) has been developed to deliver granisetron continuously over 7 days. This double-blind, phase III, non-inferiority study compared the efficacy and tolerability of the GTDS to daily oral gra

A phase III open-label study to assess s

A phase III open-label study to assess safety and efficacy of palonosetron for preventing chemotherapy-induced nausea and vomiting (CINV) in repeated cycles of emetogenic chemotherapy

✍ Kenjiro Aogi, Hiroshi Sakai, Hirohisa Yoshizawa, Norikazu Masuda, Nobuyuki Katak 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 227 KB

Pooled analysis of phase III clinical st

Pooled analysis of phase III clinical studies of palonosetron versus ondansetron, dolasetron, and granisetron in the prevention of chemotherapy-induced nausea and vomiting (CINV)

✍ Schwartzberg, Lee; Barbour, Sally Y.; Morrow, Gary R.; Ballinari, Gianluca; Thor 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 316 KB